Hippo (NYSE:HIPO - Get Free Report) had its price objective boosted by research analysts at Keefe, Bruyette & Woods from $24.00 to $26.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a "market perform" rating on the stock. Keefe, Bruyette & Woods' target price indicates a potential upside of 7.44% from the stock's current price.
Separately, Jefferies Financial Group dropped their target price on shares of Hippo from $43.00 to $30.00 and set a "buy" rating for the company in a report on Friday, April 11th.
View Our Latest Analysis on Hippo
Hippo Trading Down 1.4 %
Shares of NYSE:HIPO traded down $0.35 during trading on Tuesday, hitting $24.20. 99,538 shares of the stock were exchanged, compared to its average volume of 166,026. The company has a market cap of $606.98 million, a PE ratio of -4.64 and a beta of 1.49. The company has a fifty day moving average price of $25.96 and a two-hundred day moving average price of $26.30. Hippo has a 12-month low of $14.58 and a 12-month high of $35.44.
Hippo (NYSE:HIPO - Get Free Report) last posted its earnings results on Wednesday, March 5th. The company reported ($0.07) EPS for the quarter, topping analysts' consensus estimates of ($0.15) by $0.08. Hippo had a negative return on equity of 36.38% and a negative net margin of 37.94%. The company had revenue of $102.00 million for the quarter, compared to the consensus estimate of $97.83 million. Equities research analysts anticipate that Hippo will post -3.63 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other Hippo news, Chairman Assaf Wand sold 12,250 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $28.90, for a total transaction of $354,025.00. Following the sale, the chairman now directly owns 486,814 shares of the company's stock, valued at $14,068,924.60. This trade represents a 2.45 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Torben Ostergaard sold 21,146 shares of the business's stock in a transaction that occurred on Tuesday, February 4th. The shares were sold at an average price of $30.05, for a total transaction of $635,437.30. Following the completion of the transaction, the chief executive officer now directly owns 74,120 shares of the company's stock, valued at approximately $2,227,306. This represents a 22.20 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 50,997 shares of company stock valued at $1,469,538. Corporate insiders own 11.37% of the company's stock.
Institutional Investors Weigh In On Hippo
Hedge funds have recently made changes to their positions in the business. Barclays PLC increased its stake in Hippo by 276.5% in the third quarter. Barclays PLC now owns 25,816 shares of the company's stock valued at $435,000 after purchasing an additional 18,960 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of Hippo by 205.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 146,176 shares of the company's stock valued at $2,467,000 after acquiring an additional 98,256 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Hippo by 6.3% during the 3rd quarter. Geode Capital Management LLC now owns 442,261 shares of the company's stock valued at $7,467,000 after acquiring an additional 26,085 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Hippo by 10.5% during the 4th quarter. Vanguard Group Inc. now owns 1,020,249 shares of the company's stock worth $27,312,000 after acquiring an additional 96,959 shares during the period. Finally, Ieq Capital LLC boosted its position in shares of Hippo by 112.5% in the fourth quarter. Ieq Capital LLC now owns 107,086 shares of the company's stock worth $2,867,000 after acquiring an additional 56,684 shares during the last quarter. Institutional investors and hedge funds own 43.01% of the company's stock.
Hippo Company Profile
(
Get Free Report)
Hippo Holdings Inc provides property and casualty insurance products to individuals and business customers primarily in the United States. The company operates through three segments: Services, Insurance-as-a-Service, and Hippo Home Insurance Program. Its insurance products include homeowners' insurance against risks of fire, wind, and theft, as well as other personal lines policies from third party carriers; and personal and commercial, as well as home, auto, cyber, small business, life, specialty lines, and other insurance products.
Recommended Stories
Before you consider Hippo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hippo wasn't on the list.
While Hippo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.